BiotechTube
Everest Biotech

Everest Biotech

San Jose, United States· Est.
everestbiotech.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10M

Overview

Everest Biotech is a long-established, privately-held reagent manufacturer providing essential tools for biomedical research. Its core expertise lies in producing rigorously quality-controlled, affinity-purified goat polyclonal antibodies, which serve as cost-effective and sensitive detection tools for scientists. The company has expanded its portfolio to include matched ELISA pairs, secondary antibodies, positive control lysates, and specialized cell culture products like Shi-fix™ coverslips. Operating as a critical component supplier, it benefits from stable demand in the life science research market and maintains a reputation for batch consistency and value.

Antibodies

Technology Platform

Specialized production of anti-peptide and antigen affinity-purified goat polyclonal antibodies, supported by rigorous application-specific quality control and ISO 9001:2015 certified processes.

Funding History

2
Total raised:$10M
Series A$8M
Seed$2M

Opportunities

Leveraging the merger within the Vector Laboratories group to expand distribution and offer a more comprehensive product portfolio.
Growing demand for highly validated and reproducible research tools presents an opportunity to differentiate from lower-quality competitors.
Expansion into new reagent categories like matched assay pairs and specialized consumables addresses adjacent market needs.

Risk Factors

Intense competition from large reagent companies and technological shift toward recombinant monoclonal antibodies could pressure the traditional polyclonal market.
Operational risks associated with animal-based production, including supply chain and regulatory compliance.
Potential challenges in integrating with the parent company post-merger, which could divert focus.

Competitive Landscape

Everest Biotech competes in the fragmented life science research tools market, facing large players like Thermo Fisher Scientific and Abcam, as well as many specialized antibody boutiques. Its differentiation is based on high-quality, application-validated goat polyclonals and ISO certification, targeting researchers who prioritize reliability over cost. The merger with Vector Laboratories strengthens its position by creating a broader portfolio and distribution network.

More companies in Biologics / Biosimilars →More companies in United States →